Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 967 | 1,613 | 407 | 163 | 174 |
| Gross Profit | 967 | 1,613 | 407 | 163 | 174 |
| Operating Expenses | 33,438 | 29,498 | 28,103 | 36,559 | 23,431 |
| Operating Income | -32,471 | -27,885 | -27,696 | -36,396 | -23,257 |
| Other Income | 3,110 | 1,398 | 912 | 392 | 207 |
| Pre-tax Income | -29,361 | -26,487 | -26,784 | -36,004 | -23,050 |
| Net Income Continuous | -29,361 | -26,487 | -26,784 | -36,004 | -23,050 |
| Net Income | $-29,361 | $-26,487 | $-26,784 | $-36,004 | $-23,050 |
| EPS Basic Total Ops | -0.62 | -0.57 | -0.57 | -0.77 | -0.49 |
| EPS Basic Continuous Ops | -0.62 | -0.56 | -0.57 | -0.77 | -0.49 |
| EPS Diluted Total Ops | -0.62 | -0.57 | -0.57 | -0.77 | -0.49 |
| EPS Diluted Continuous Ops | -0.62 | -0.56 | -0.57 | -0.77 | -0.49 |
| EBITDA(a) | $-33,001 | $-27,734 | $-26,967 | $-35,119 | $-21,674 |